Research Options:
Week of Expected Pricing Withdrawn
Company Name CIRIUS THERAPEUTICS, INC.
Proposed Ticker N/A
CUSIP N/A
Business Description A clinical-stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and metabolic diseases. Our lead product candidate,
Lead Underwriter Citigroup Global Markets Inc Credit Suisse Securities (USA) LLC
Co-Managers Needham & Company, LLC ,Wedbush Securities Inc
Initial Shares N/A
Revised Initial Shares N/A
Initial Price N/A
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 
   
  © 2024 ICE Data Services. All rights reserved.